JapanChina Trade Chiefs Hold First FacetoFace Talks at APEC Since Dispute Trainline Raises FullYear Guidance for Second Time in 2025 Meta Broadcom and Industry Leaders Launch 125 Million Semiconductor Research Hub at UCLA Traders Speculate Next US Government Stake IonQ Micron Anduril Lead Predictions Telsey Advisory Group Lowes Continues to Execute Amid Housing Market Weakness The Federal Reserve Faces Diminishing Rationale for Interest Rate Cuts Amid Stubborn Cost Pressures C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage Fox Factory Holding Corp FOXF Q1 2026 Earnings EPS Surges Past Estimates as Cost Cuts Take Hold JOBY Q1 2026 Earnings EPS Beat by 39 Highlights Progress in eVTOL Development Path OXM Q1 2026 Earnings EPS Misses Estimates by Wide Margin Shares Gain Modular Medical Inc MODD Q3 2025 Earnings EPS Miss Weighs Despite Positive Stock Reaction CEG Q1 2026 Earnings EPS Beats Estimates as Constellation Capitalizes on Nuclear and Clean Energy Demand Eli Lilly LLY Rises 224 as Stock Flirts with Key Resistance at 1118 Blue Bird Corporation BLBD Edges Lower Amid Market Consolidation Crown Castle CCI Slips 06 as Telecom REIT Tests Key Support Zone JBT Marel Corporation JBTM Gains 19 as Stock Tests Key Resistance at 141 Plum Acquisition Corp IV Unit PLMKU Gains 168 Testing Key Technical Levels WRB Q1 2026 Earnings Strong EPS Beat Driven by Solid Underwriting and Investment Results KRMN Q1 2026 Earnings EPS Misses Estimates Stock Declines Sharply Compass Therapeutics Q1 2026 Earnings Narrowerthanexpected Loss Fuels Investor Optimism CPHC Q2 2025 Earnings Net Loss Per Share of 006 Reported Stock Edges Higher Canopy Growth CGC Q1 2026 Earnings Deep Loss Widens as Cannabis Operator Faces Margin Pressures Alcon ALC Q1 2026 Earnings EPS Beats Estimates as Surgical and Vision Care Segments Drive Profitability Train Blast in Quetta Injures Dozens Raises Security Concerns for Pakistans Transport Sector BioVie Inc Q1 2026 Earnings EPS Beat Amid Ongoing Clinical Development Stellus Capital Investment SCM Gains 167 as Shares Approach Key Resistance 960 Level in Focus